Search results
Results from the WOW.Com Content Network
It now expects revenue in the range of $59.5 billion to $62.5 billion, up from $58.5 billion to $61.5 billion — with a combined $8.5 billion expected from the COVID vaccine and COVID treatment ...
The respiratory vaccines are priced lower than other vaccines, like Merck's HPV vaccine, Gardasil, which has a list price of $300 or more. (List price for Moderna's COVID vaccine: $110.) (List ...
Shares of the vaccine maker tumbled 17.1% to $65.88 at midday. The company expects sales between $2.5 billion and $3.5 billion in 2025, below analysts' forecast of $3.74 billion, according to LSEG ...
v. t. e. The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [ 1 ] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations. [ 32 ] It contains a recombinant spike protein from the SARS-CoV-2 Omicron variant lineage JN.1.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
Medical uses. The Pfizer–BioNTech COVID-19 vaccine is used to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus, by eliciting an immune response to the S antigen. [ 1 ][ 2 ][ 31 ][ 40 ] The vaccine is used to reduce morbidity and mortality from COVID-19. [ 35 ]
In 2019 Moderna reported revenues of $60 million, and by 2022 made its debut on the Fortune 500 with over $18 billion in revenue, boosted by its mRNA COVID-19 vaccine during a time when it was in ...
The Access to COVID-19 Tools Accelerator (ACT Accelerator or ACT-A), or the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020. [ 1 ]